You have 9 free searches left this month | to do more
Showing 1 - 25 of
292 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-14
Dec 14, 2021
U
Recruiting
  • Lymphoma
  • Brentuximab Vedotin
  • BeEAM Regimen
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
2021-07-29
Jul 29, 2021
M
Active, not recruiting
  • Hodgkin's Lymphoma
  • brentuximab vedotin (SGN-35)
  • Brentuximab Vedotin (SGN-35)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-06-11
Jun 11, 2021
E
Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
2021-12-14
Dec 14, 2021
M
Recruiting
  • Mycosis Fungoides
  • +2 more
  • brentuximab vedotin
  • Stanford, California
  • +7 more
2021-11-03
Nov 3, 2021
L
Not yet recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Brentuximab vedotin
  • (no location specified)
2021-11-24
Nov 24, 2021
U
Active, not recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Dept. of Medicine, Cologne University Hospital
2021-06-11
Jun 11, 2021
C
Recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Brentuximab Vedotin
  • Nivolumab
  • Duarte, California
    City of Hope Medical Center
2021-11-02
Nov 2, 2021
J
Recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Bendamustine Hydrochloride
  • Brentuximab Vedotin
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2021-12-17
Dec 17, 2021
W
Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Saint Louis, Missouri
  • +1 more
2021-07-31
Jul 31, 2021
M
Active, not recruiting
  • Hodgkin Lymphoma
  • Mocetinostat Plus Brentuximab Vedotin
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-02-18
Feb 18, 2021
U
Recruiting
  • T Cell Lymphoma
  • Brentuximab Vedotin
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
2021-11-29
Nov 29, 2021
C
Not yet recruiting
  • Hodgkin Lymphoma
  • (no location specified)
2021-12-17
Dec 17, 2021
F
Recruiting
  • Cutaneous T-cell Lymphoma (CTCL)
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
2021-03-25
Mar 25, 2021
A
Active, not recruiting
  • ALK+ Anaplastic Large Cell Lymphoma
  • Wien, Austria
    Universitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
2021-07-20
Jul 20, 2021
C
Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +2 more
2021-06-12
Jun 12, 2021
F
Active, not recruiting
  • Lymphatic Diseases
  • Brentuximab Vedotin
  • Bologna, Italy
  • +3 more
2021-12-17
Dec 17, 2021
Y
Not yet recruiting
  • PTLD
  • +8 more
  • New Haven, Connecticut
  • +1 more
2021-10-28
Oct 28, 2021
U
Recruiting
  • Classical Hodgkin Lymphoma
  • Brentuximab Vedotin
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
2020-11-26
Nov 26, 2020
F
Terminated
  • Lymphatic Diseases
  • Bologna, BO, Italy
  • +4 more
2021-05-26
May 26, 2021
M
Terminated
  • Germ Cell Tumor
  • Minneapolis, Minnesota
    University of Minnesota
2020-11-12
Nov 12, 2020
C
Not yet recruiting
  • Lymphoma, T-Cell, Peripheral
  • Adcetris 50 MG Injection
  • +4 more
  • Brno, Czechia
  • +6 more
2021-08-26
Aug 26, 2021
T
Active, not recruiting
  • HIV Infection
  • +3 more
  • brentuximab vedotin
  • +3 more
  • Clamart, France
  • +5 more
2021-12-06
Dec 6, 2021
T
Recruiting
  • Untreated CD30-Positive Hodgkin's Lymphoma
  • Brentuximab vedotin (Genetical Recombination)
  • Tokyo, Japan
    Takeda Selected Site
2021-03-23
Mar 23, 2021
U
Completed
  • Hodgkin Lymphoma, Adult
  • Brentuximab vedotin
  • ABVD
  • Duarte, California
  • +5 more
2021-11-08
Nov 8, 2021